Effect of Arotinolol Hydrochloride on Cardiovascular Events in Hypertensive Haemodialysis Patients

NCT01351636 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease

Interventions

DRUG: Arotinolol Hydrochloride
DRUG: Non arotinolol group

Sponsor

Sumitomo Pharma (Suzhou) Co., Ltd.